Clinical trial
Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Travelling Across Multiple Time Zones. A Pilot Study.
NCT03668808 is registered in ClinicalTrials.gov with Sansum Diabetes Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Travelling Across Multiple Time Zones. A Pilot Study.
- Lead sponsor
- Sansum Diabetes Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 16, 2018
- Completion date
- September 19, 2020
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.